Publication | Open Access
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
432
Citations
23
References
2021
Year
Phase 1/2Lymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyPathologyOncologyRadiation OncologyRefractory B-cell Malignancies
| Year | Citations | |
|---|---|---|
Page 1
Page 1